Gerresheimer AG (GXI) PT Set at €80.00 by Credit Suisse Group

Gerresheimer AG (ETR:GXI) received a €80.00 ($94.12) price target from investment analysts at Credit Suisse Group in a report issued on Tuesday. The brokerage presently has a “buy” rating on the stock.

Several other equities research analysts have also issued reports on the company. Goldman Sachs Group, Inc. (The) set a €69.50 ($81.76) price objective on Gerresheimer AG and gave the company a “neutral” rating in a research note on Wednesday, October 4th. Commerzbank Ag set a €77.00 ($90.59) price objective on Gerresheimer AG and gave the company a “buy” rating in a research note on Thursday, September 28th. HSBC Holdings plc set a €65.00 ($76.47) price objective on Gerresheimer AG and gave the company a “neutral” rating in a research note on Thursday, September 28th. Hauck & Aufhaeuser set a €63.50 ($74.71) price objective on Gerresheimer AG and gave the company a “neutral” rating in a research note on Thursday, September 21st. Finally, Independent Research GmbH set a €68.00 ($80.00) price objective on Gerresheimer AG and gave the company a “neutral” rating in a research note on Tuesday, September 5th. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have issued a buy rating to the company’s stock. Gerresheimer AG has an average rating of “Hold” and a consensus target price of €72.94 ($85.81).

Gerresheimer AG (GXI) opened at 65.761 on Tuesday. The stock’s 50 day moving average price is €65.32 and its 200-day moving average price is €70.43. The firm has a market cap of €2.06 billion and a PE ratio of 18.216. Gerresheimer AG has a 12-month low of €59.97 and a 12-month high of €79.47.

TRADEMARK VIOLATION WARNING: “Gerresheimer AG (GXI) PT Set at €80.00 by Credit Suisse Group” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://sportsperspectives.com/2017/10/12/gerresheimer-ag-gxi-pt-set-at-80-00-by-credit-suisse-group.html.

Gerresheimer AG Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply